We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WALTHAM, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe...
– Advancing Phase 2 clinical trials of verekitug in patients with severe asthma and CRSwNP – – Commenced startup for a Phase 2 clinical trial in COPD; on track for first patient to be dosed in H2...
WALTHAM, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
WALTHAM, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.29 | -10.0306614104 | 22.83 | 24.975 | 20.23 | 245189 | 22.19777819 | CS |
4 | -5.48 | -21.0607225211 | 26.02 | 26.7 | 17.26 | 233273 | 21.36395468 | CS |
12 | -0.96 | -4.46511627907 | 21.5 | 29.35 | 17.26 | 306279 | 23.4720001 | CS |
26 | -0.96 | -4.46511627907 | 21.5 | 29.35 | 17.26 | 306279 | 23.4720001 | CS |
52 | -0.96 | -4.46511627907 | 21.5 | 29.35 | 17.26 | 306279 | 23.4720001 | CS |
156 | -0.96 | -4.46511627907 | 21.5 | 29.35 | 17.26 | 306279 | 23.4720001 | CS |
260 | -0.96 | -4.46511627907 | 21.5 | 29.35 | 17.26 | 306279 | 23.4720001 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions